Related Experiment Video
Updated: Nov 2, 2025
19:53
Single-stage Dynamic Reanimation of the Smile in Irreversible Facial Paralysis by Free Functional Muscle Transfer
Published on: March 1, 2015
106.1K
COVID-19 presenting as acute transient flaccid limb paralysis
V Rajesh1, Jolsana Augustine1, R Divya1
1Department of Pulmonary Medicine, Rajagiri Hospital, Chunangamvely, Aluva, Kochi, Kerala, India.
Journal of Family Medicine and Primary Care
|June 14, 2021
Summary
The novel coronavirus pandemic caused global disruption. A young man with periodic paralysis was diagnosed with COVID-19, highlighting the need for vigilance in identifying infections, even in atypical cases.
Area of Science:
- Neurology
- Infectious Diseases
Background:
- The 2020 novel coronavirus pandemic (COVID-19) significantly impacted global health.
- India became the second most affected country, necessitating widespread diagnostic vigilance.
Observation:
- A young male patient presented with symptoms of periodic paralysis.
- This presentation is not typically associated with COVID-19 infection.
Findings:
- The patient was eventually diagnosed with COVID-19.
- This case underscores the diverse and sometimes unexpected clinical manifestations of SARS-CoV-2.
Implications:
- Healthcare providers must maintain a high index of suspicion for COVID-19, even in patients with unusual symptoms.
- Broadening diagnostic considerations is crucial for effective pandemic control.
Related Concept Videos
01:28Depolarizing Blockers: Mechanism of Action
2.2K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.2K
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
109
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
109
01:28Classification of Skeletal Muscle Relaxants
2.8K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.8K